Plunkett Research Online: Lixte Biotechnology Holdings Inc

LIXTE BIOTECHNOLOGY HOLDINGS INC (LIXT) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays.....


LIXTE BIOTECHNOLOGY HOLDINGS INC

Ticker: LIXT
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 631 942 7959
Fax: 928 982 5050
Address: 248 Route 25A, No. 2
East Setauket, NY 11733 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Bastiaan van der BaanCEO/Chairman of the Board/Director/President
Robert WeingartenCFO/Vice President
See More
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture